Pancreatic Cancer Research

ResearcherEmory UniversityActive in the last 2 years

Hui Mao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0147-6022; OpenAlex author ID A5068714594; NIH RePORTER profile ID 1967986. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
4
Labs led
1
Collaborators
10
Papers, trials and grants by year

2013: 1 paper · 2014: 1 grant · 2015: 1 paper, 1 grant · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper, 1 grant · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 grant

Papers 7

  1. Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma. First author DOI 10.1002/wnan.1793↗
  2. Transcriptomic Analyses and Potential Therapeutic Targets of Pancreatic Cancer With Concomitant Diabetes. Co-author DOI 10.3389/fonc.2020.563527↗
  3. Targeting of an antecedent proteinase by an activatable probe with deep tissue penetration facilitates early visualization and dynamic malignancy evaluation of… Co-author DOI 10.1039/c9bm00441f↗
  4. Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy. Co-author DOI 10.1016/j.canlet.2016.11.030↗
  5. Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer. Co-author DOI 10.2147/ijn.s92722↗
  6. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. Co-author DOI 10.1021/acsnano.5b01288↗
  7. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. Co-author DOI 10.1021/nn3043463↗

Grants 4

  1. Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer R01CA261251↗
  2. Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy U01CA198913↗
  3. MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer R01CA154846↗
  4. Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer U01CA151810↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lily Yang · 5 shared papers, 4 shared grants, 2013–2025 · strength 2.35
  2. Lei Zhu · 2 shared papers, 2017–2022 · strength 0.34
  3. Tingting Xu · 2 shared papers, 2019–2020 · strength 0.25
  4. Shenghong Ju · 2 shared papers, 2019–2020 · strength 0.25
  5. David A. Kooby · 2 shared papers, 2015–2017 · strength 0.13
  6. Hongbo Chen · 1 shared paper, 2016 · strength 0.06
  7. Jing Huang · 1 shared paper, 2016 · strength 0.06
  8. Hongyu Zhou · 1 shared paper, 2015 · strength 0.05
  9. Liya Wang · 1 shared paper, 2015 · strength 0.05
  10. Gee Young Lee · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.